Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

• Andrew H. Lipsky,
• Jay N. Lozier,
• Adrian Wiestner

Affiliations

Andrew H. Lipsky

Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD;Department of Internal Medicine, Montefiore Medical Center, Bronx, New York, NY, USA

Jay N. Lozier

Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD

Adrian Wiestner

Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD